Lawsuit for Investors in ERBA Diagnostics Inc (NYSEMKT:ERB)

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Lawsuit for Investors in ERBA Diagnostics Inc (NYSEMKT:ERB) Shares Announced by Shareholders Foundation

SAN DIEGO, Jan. 20, 2016 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit was filed in Florida on behalf of certain purchasers of shares of ERBA Diagnostics Inc (NYSEMKT:ERB) over alleged Securities Laws Violations by ERBA Diagnostics.

Investors who purchased shares of ERBA Diagnostics Inc (NYSEMKT:ERB) have certain options and for certain investors are short and strict deadlines running. Deadline: February 1, 2016. (NYSEMKT:ERB) investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The plaintiff claims that defendants made certain allegedly false and/or misleading statements and/or allegedly failed to disclose that ERBA Diagnostics Inc lacked adequate controls over financial reporting, that ERBA Diagnostics Inc’s financial statements between April 14, 2014 and November 23, 2015 were materially false and misleading, and that as a result of the foregoing, Defendants’ statements regarding ERBA’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis.

On November 20, 2015, ERBA Diagnostics Inc announced that the Audit Committee of the Company's Board of Directors concluded that the Company's financial statements for each of the years ended December 31, 2014 and 2013 and for each of the interim periods ended March 31, 2015 and June 30, 2015 should no longer be relied upon. In addition, ERBA Diagnostics Inc stated that the Company intends to restate its financial statements for each of the years ended December 31, 2014 and 2013 and for each of the interim periods ended March 31, 2015 and June 30, 2015 by filing amendments to its Annual Report on Form 10-K for the year ended December 31, 2014, which will also include details regarding adjustments in the portion of the Non-Reliance Period occurring during the year ended December 31, 2013, and its Quarterly Reports for the periods ended March 31, 2015 and June 30, 2015 as soon as practicable.

Those who purchased ERBA Diagnostics Inc (NYSEMKT:ERB) shares have certain options and should contact the Shareholders Foundation, Inc. by e-mail at mail@shareholdersfoundation.com or call +1 (858) 779-1554.

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Shareholders Foundation, Inc. Michael Daniels +1 (858) 779-1554 mail@shareholdersfoundation.com 3111 Camino Del Rio North Suite 423 San Diego, CA 92108

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Growth Outlook for the Packaging Robots Market to 2032

Updated Category News Views 128

The Expanding Landscape of Packaging Robots The Packaging Robots Market is on an exciting trajectory, projected to soar from an estimated USD 6.02 billion in 2023 to an impressive USD 16.67 billion by 2032. This remarkable growth is fueled by continuous technological advancements and the ever-increasing demand for automation, as businesses strive for greater efficiency in...

Continue Reading
Analyzing the Short Interest Trends for AutoZone Inc

Updated Category News Views 88

Understanding AutoZone Inc's Short Interest AutoZone Inc (NYSE: AZO) has recently seen a noteworthy rise in its short interest, which now stands at approximately 5.91% higher than its previous report. This increase translates to around 317 thousand shares being sold short, representing 2.15% of the total regular shares available for trading. Given its trading patterns, it...

Continue Reading
Join the Fight: Investors Urged to Act Against Flywire's Missteps

Updated Category News Views 180

Critical Insights into Flywire Corporation's Recent Challenges In light of recent events, investors in Flywire Corporation (NASDAQ: FLYW) are presented with a pivotal opportunity to address potential securities fraud claims. Allegations suggest that the company might have communicated misleading business information to the public, raising concerns among its shareholders....

Continue Reading
LEPAS L8: A Game-Changer for Electric Vehicle Enthusiasts

Updated Category News Views 308

LEPAS L8: Redefining the Future of NEVs The innovative leap forward in the world of electric vehicles comes with Chery Group's brand new energy vehicle (NEV) brand, LEPAS, and its latest offering, the L8 model. The introduction of the L8 marks a significant milestone for Chery as it establishes a new standard in driving sophistication. This model is poised to make waves...

Continue Reading
Integra LifeSciences Launches Pediatric Registry for AERA System

Updated Category News Views 128

Integra LifeSciences Initiates Pediatric AERA Registry Integra LifeSciences Holding Corporation (Nasdaq: IART), a premier global leader in medical technology, has taken a significant step forward by enrolling the first patient in the Acclarent AERA Pediatric Registry. This multi-center observational registry aims to evaluate the real-world applications of the AERA...

Continue Reading